Search Results 161-170 of 17377 for GLP-1 secretion

  1. A Study to Evaluate the Effects of Insulin Deprivation on Rate of Plasma Proteins Synthesis in Type 1 Diabetes Mellitus - Mayo Clinic

    The purpose of this study is to determine the effects of transient insulin deprivation in people with type 1 DM (T1DM) and Total Pancreatomy on synthesis of ...

  2. Pioglitazone and glimepiride (oral route) - Side effects & dosage - Mayo Clinic

    Glimepiride stimulates the release of insulin ... Adults—At first, 1 tablet (either pioglitazone 30 ... Adults—At first, 1 tablet (pioglitazone 30 ...

  3. New vein of research focuses on inducing pancreatic hypothermia to reduce injury associated with mild and severe acute pancreatitis - Mayo Clinic

    Acute pancreatitis (AP) is the most common hospital gastroenterology discharge diagnosis. This condition is characterized by sudden and severe abdominal ...

  4. Amylase/lipase/pancrelipase/protease (oral route) - Side effects & dosage - Mayo Clinic

    ... release capsules in children. Safety and efficacy ... For patients taking the delayed-release capsules: ... You may report side effects to the FDA at 1-800-FDA-1088 ...

  5. A Study of Adjustable Gastric Banding and Its Effects on After Meal Glucose Metabolism, Independent of Weight Loss - Mayo Clinic

    Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and ...

  6. Heart disease - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the ... Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri ...

  7. The Effects of Glucagon on Hepatic Metabolism - Mayo Clinic

    1/2. During the early phases (phases 1 and 2), researchers assess safety ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a ...

  8. Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes - Mayo Clinic

    This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.

  9. A Study to Compare Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments for Type 1 Diabetes Patients - Mayo Clinic

    Clinical diagnosis, based on investigator assessment, of type 1 diabetes for at least one. ... GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors ...

  10. Heart Failure Clinical Trials - Mayo Clinic Research

    Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) Rochester, MN ... discharge period will be associated with greater ... discharge on heart failure ...